Abstract
Context: The impact of abnormal cortisol secretion on cognitive functions in patients with mild autonomous cortisol secretion (MACS) remains uncertain. Objective: To assess cognitive functions, determine serum brain-derived neurotrophic factor (BDNF) concentration in patients with MACS, and investigate the association between cognitive subdomains and BDNF. Methods: We prospectively recruited 84 participants - 28 patients with MACS, 28 patients with nonfunctional adrenal adenoma (NFAA), and 28 control subjects matched for age, gender, body mass index (BMI), visceral adiposity, and educational level. The serum BDNF concentration of participants was measured. The Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition-focused interviews and Montreal Cognitive Assessments (MoCA) were carried out by an experienced psychiatrist. Results: Patients with MACS had a higher serum BDNF concentration than the NFAA (P =. 001), while that of patients with NFAA was lower than the controls (P =. 044). Linear regression analysis revealed BMI and morning cortisol after overnight 1 mg dexamethasone (DST) were mostly associated with BDNF (P
Author supplied keywords
Cite
CITATION STYLE
Barlas, T., Aksu, M. H., Cerit, E. T., Yalcin, M. M., Akturk, M., Balos Toruner, F., … Eroglu Altinova, A. (2024). Cognitive functions and the brain-derived neurotrophic factor in patients with mild autonomous cortisol secretion. European Journal of Endocrinology, 191(1), 31–37. https://doi.org/10.1093/ejendo/lvae070
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.